An Efficacy Study for Epoetin Alfa in Anemic Patients With Myelodysplastic Syndromes

form= solution for injection, route= subcutaneous use, weekly injections for 24 to 48 weeks

type = range, unit= IU/Kg, number= 337.5 to 1050 IU/Kg, form= solution for injection, route= subcutaneous use, weekly injections (max 40,000 IU per week for first 8 weeks of treatment, max 80,000 IU per week later) using pre-filled 1mL 40,000 IU syringes for 24 to 48 weeks